It’s Time to Rein in Exorbitant Pharmaceutical Prices
Harvard Business Review
SEPTEMBER 22, 2015
As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. There are compelling reasons, however, to consider doing so for pharmaceuticals.